HCW Biologics Held $17.4M In Cash, Cash Equivalents And U.S. Treasury Bills Of Short Duration Expected To Fund Operations Into Q4 2024
$HCWB
Biotechnology: Pharmaceutical Preparations
Health Care
HCW Biologics Held $17.4M In Cash, Cash Equivalents And U.S. Treasury Bills Of Short Duration Expected To Fund Operations Into Q4 2024